Literature DB >> 11602542

Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction.

P Lancellotti1, T Benoit, P Rigo, L A Pierard.   

Abstract

OBJECTIVE: To compare the relative accuracy of dobutamine stress echocardiography (DSE) and quantitative technetium-99m sestamibi single photon emission computed tomography (mibi SPECT) for detecting infarct related artery stenosis and multivessel disease early after acute myocardial infarction.
DESIGN: Prospective study.
SETTING: University hospital.
METHODS: 75 patients underwent simultaneous DSE and mibi SPECT at (mean (SD)) 5 (2) days after a first acute myocardial infarct. Quantitative coronary angiography was performed in all patients after imaging studies.
RESULTS: Significant stenosis (> 50%) of the infarct related artery was detected in 69 patients. Residual ischaemia was identified by DSE in 55 patients and by quantitative mibi SPECT in 49. The sensitivity of DSE and mibi SPECT for detecting significant infarct related artery stenosis was 78% and 70%, respectively, with a specificity of 83% for both tests. The combination of DSE and mibi SPECT did not change the specificity (83%) but increased the sensitivity to 94%. Mibi SPECT was more sensitive than DSE for detecting mild stenosis (73% v 9%; p = 0.008). The sensitivity of DSE for detecting moderate or severe stenosis was greater than mibi SPECT (97% v 74%; p = 0.007). Wall motion abnormalities with DSE and transient perfusion defects with mibi SPECT outside the infarction zone were sensitive (80% v 67%; NS) and highly specific (95% v 93%; NS) for multivessel disease.
CONCLUSIONS: DSE and mibi SPECT have equivalent accuracy for detecting residual infarct related artery stenosis of >/= 50% and multivessel disease early after acute myocardial infarction. DSE is more predictive of moderate or severe infarct related artery stenosis. Combined imaging only improves the detection of mild stenosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602542      PMCID: PMC1729965          DOI: 10.1136/heart.86.5.510

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation.

Authors:  K L Gould
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

2.  Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction.

Authors:  S C Smart; T Knickelbine; T R Stoiber; M Carlos; J C Wynsen; K B Sagar
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

3.  Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?

Authors:  C W White; C B Wright; D B Doty; L F Hiratza; C L Eastham; D G Harrison; M L Marcus
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

4.  Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction.

Authors:  J A Ambrose; S L Winters; R R Arora; J I Haft; J Goldstein; K P Rentrop; R Gorlin; V Fuster
Journal:  J Am Coll Cardiol       Date:  1985-12       Impact factor: 24.094

5.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion.

Authors:  C Berthe; L A Pierard; M Hiernaux; G Trotteur; P Lempereur; J Carlier; H E Kulbertus
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

6.  Echocardiographic prediction of the site of coronary artery obstruction in acute myocardial infarction.

Authors:  L A Pierard; M Sprynger; J Carlier
Journal:  Eur Heart J       Date:  1987-02       Impact factor: 29.983

7.  Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.

Authors:  R S Gibson; D D Watson; G B Craddock; R S Crampton; D L Kaiser; M J Denny; G A Beller
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Authors:  E J Topol; R M Califf; B S George; D J Kereiakes; C W Abbottsmith; R J Candela; K L Lee; B Pitt; R S Stack; W W O'Neill
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

9.  Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction.

Authors:  K A Brown; R M Weiss; J P Clements; F J Wackers
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

10.  Limited exercise testing soon after myocardial infarction. Correlation with early coronary and left ventricular angiography.

Authors:  K M Schwartz; J D Turner; L T Sheffield; D I Roitman; S Kansal; S E Papapietro; J A Mantle; C E Rackley; R O Russell; W J Rogers
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

View more
  2 in total

1.  Mechanisms of regional wall motion abnormalities in contrast-enhanced dobutamine stress echocardiography.

Authors:  N Heinicke; B Benesch; T Kaiser; K Debl; M Segmüller; J Schönberger; J Marienhagen; C Eilles; G A J Riegger; S Holmer; A Luchner
Journal:  Clin Res Cardiol       Date:  2006-09-28       Impact factor: 5.460

2.  Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography.

Authors:  E Biagini; A F L Schinkel; J J Bax; V Rizzello; R T van Domburg; B J Krenning; M Bountioukos; C Pedone; E C Vourvouri; C Rapezzi; A Branzi; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.